Live from the NIH registry
Studies recruiting near Evansville right now
Top 25 of 77 recruiting studies, sorted by proximity — each links to its official registry page
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Evansville, Indiana (1.5 mi)
· Sponsor: Medtronic
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: NRG Oncology
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Deaconess Midtown Hospital /ID# 270572 — Evansville, Indiana (1.5 mi)
· Sponsor: AbbVie
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Deaconess Gateway Hospital — Newburgh, Indiana (7.6 mi)
· Sponsor: Biosense Webster, Inc.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Attention-Deficit/Hyperactivity Disorder
Phase 4
Interventional 286 participants sought
Qualmedica Research, LLC. — Evansville, Indiana (1.5 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
Growth
N/A
Interventional 214 participants sought
Springs Medical Research — Owensboro, Kentucky (27.3 mi)
· Sponsor: Mead Johnson Nutrition
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Evansville, Indiana (1.5 mi)
· Sponsor: Alnylam Pharmaceuticals
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Synexus Clinical Research - Evansville — Evansville, Indiana (1.5 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Deaconess Clinic- Gateway — Newburgh, Indiana (7.6 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 3
Interventional 531 participants sought
Deaconess Midtown Hospital /ID# 282134 — Evansville, Indiana (1.5 mi)
· Sponsor: AbbVie
Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation
Lung Cancer Screening
N/A
Interventional 330 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: Timothy Mullett
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Deaconess GI Specialty Center — Newburgh, Indiana (7.6 mi)
· Sponsor: Eli Lilly and Company
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 1
Interventional 25 participants sought
Clinical Site 2 — Owensboro, Kentucky (27.3 mi)
· Sponsor: Corvus Pharmaceuticals, Inc.
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis
Phase 3
Interventional 350 participants sought
Deaconess GI Specialty Center — Newburgh, Indiana (7.6 mi)
· Sponsor: Ipsen
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Asthma
Phase 3
Interventional 138 participants sought
GSK Investigational Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: GlaxoSmithKline
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 3
Interventional 3,003 participants sought
AURORA-1 Clinical Site — Evansville, Indiana (1.5 mi)
· Sponsor: Ascletis Pharma (China) Co., Limited
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: AstraZeneca
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Research Integrity, LLC — Owensboro, Kentucky (27.3 mi)
· Sponsor: Boehringer Ingelheim
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Owensboro Health Mitchell Memorial Cancer Center — Owensboro, Kentucky (27.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: AstraZeneca
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Newburgh, Indiana (7.6 mi)
· Sponsor: DalCor Pharmaceuticals
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Phase 3
Interventional 5,000 participants sought
Research Site — Evansville, Indiana (1.5 mi)
· Sponsor: AstraZeneca
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Deaconess Clinic - GI Specialty Center — Newburgh, Indiana (7.6 mi)
· Sponsor: Regeneron Pharmaceuticals
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Owensboro, Kentucky (27.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Deaconess Clinic - Gateway Health Center /ID# 247589 — Newburgh, Indiana (7.6 mi)
· Sponsor: AbbVie